Atellica生化与免疫分析仪20项检测的多中心性能评价及Sigma度量
欧洲六家早期采用者实验室依据CLSI方案评估Atellica生化与免疫分析仪20项检测的精密度、检测能力、线性和方法比对。合并数据计算Sigma度量,18/20项检测Sigma>4,尿素氮(3.1)和钠(3.9)可接受,后者归因于五个站点中一个站点的较高不精密度。结果验证了制造商声称的方法适用于临床实验室。
要点
- 18/20项检测合并Sigma度量>4,性能良好或更优。
- 尿素氮Sigma为3.1、钠为3.9,性能可接受。
- 钠Sigma偏低归因于五个站点中一个站点的较高不精密度。
核心结论
- Atellica生化与免疫分析仪20项检测中18项合并Sigma度量>4,性能良好或更优。
- 尿素氮(3.1)和钠(3.9)的Sigma度量可接受。
- 结果验证制造商声称方法适用于临床实验室。
研究设计与样本
- 欧洲六家早期采用者临床实验室参与的多中心性能评价研究。
- 依据CLSI方案进行精密度、检测能力、线性和方法比对研究。
主要发现
- 空白限和检测结果与制造商声称一致。
- 大多数检测在测试范围内呈线性。
- 20项检测中18项合并Sigma度量>4。
- 尿素氮合并Sigma度量为3.1,钠为3.9。
关键数值与推荐
- 生化检测采用CLIA总允许误差(TEa)目标,免疫检测采用RiliBÄK TEa目标。
- Sigma度量计算公式:Sigma度量=%TEa-%bias/%CV。
- 合并%CV由各站点不精密度合并计算。
- 偏倚通过Deming回归(电解质用Passing-Bablok回归)与ADVIA Chemistry或ADVIA Centaur系统比对计算。
- 103个单站点Sigma度量计算使用单站点不精密度和合并偏倚。
临床怎么用
- 合并Sigma度量>4提示检测性能良好,可用于临床实验室常规检测。
- 尿素氮和钠的Sigma度量可接受,但需关注不精密度较高站点。
局限性
- 钠Sigma度量偏低归因于五个站点中一个站点的较高不精密度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background The Atellica Solution comprises chemistry (CH) and immunoassay (IM) analyzers. Recently, six early adopter clinical laboratories across Europe evaluated the analytical performance of 20 CH and IM assays. To measure analytical performance quality, Sigma metrics were calculated for individual-site and pooled-site results. Methods Precision, detection capability, linearity, and method comparison studies were performed according to Clinical Laboratory Standards Institute protocols. Global Sigma metrics across sites were calculated from pooled data at the medical decision level using total allowable error (TEa) goals from CLIA for CH assays, and TEa goals from RiliBÄK for IM assays; and, the equation: Sigma metrics=%TEa-%bias/%CV. A pooled %CV was calculated by combining the imprecision obtained from individual sites. Bias calculations were performed against the ADVIA Chemistry system or ADVIA Centaur system using Deming regression analysis (Passing-Bablok regression for electrolytes) on the pooled-site data. The 103 individual-site Sigma metric calculations used individual-site imprecision and pooled-bias. Results The limits of blank and detection results agreed with the manufacturer's claims. Most assays were linear across the assay range tested. Pooled Sigma metrics were good or better (>4 Sigma) for 18 of 20 assays; and, acceptable for urea nitrogen (3.1) and sodium (3.9), the latter values attributable to higher imprecision at one of five sites. Conclusions Sigma metrics for data generated across multiple real-world sites evaluating the Atellica Solution demonstrated good or better performance of greater than 4 Sigma for 18 of 20 assays tested. Overall, results verified the manufacturer's claims that methods were fit for use in clinical laboratories.
引用
- Fasano T, Bedini JL, Fle PA, et al. Multi-site performance evaluation and Sigma metrics of 20 assays on the Atellica chemistry and immunoassay analyzers. Clin Chem Lab Med. 2019. PMID: 31639101. doi:10.1515/cclm-2019-0699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。